<DOC>
	<DOCNO>NCT00076544</DOCNO>
	<brief_summary>The purpose open-label study give chronic severe pain patient exist intrathecal pump system access ziconotide .</brief_summary>
	<brief_title>Ziconotide Effectiveness Safety Trial Patients With Chronic Severe Pain</brief_title>
	<detailed_description />
	<mesh_term>Ziconotide</mesh_term>
	<mesh_term>omega-Conotoxins</mesh_term>
	<criteria>Each patient must chronic severe pain malignant nonmalignant etiology inadequate pain relief intolerance conventional therapy . Each patient must predict life expectancy great equal 6 week relative baseline . Each patient must able respond Visual Analog Scale Pain Intensity ( VASPI ) . Each patient must implant programmable SynchroMed infusion device CADDMicro external programmable infusion device spinal catheter ( hereafter `` IT pump spinal catheter '' ) prior enrollment trial . ( If patient external pump , Investigator must ensure patient low risk infection patient capable maintaining good personal hygiene . The Investigator must demonstrate ability successfully manage patient external pump prior enrol patient trial . ) Each patient must least 18 year age . Each patient must competent give write informed consent give write informed consent prior performance studyrelated procedure . Reasonable accommodation visually impaired patient allow . Each patient willing able comply protocol requirement . Each female patient childbearing potential must agree use adequate contraceptive method PRIALT determine Investigator . Presence pregnancy lactation . Participation another investigational drug device trial within precede 30 day . Presence known hypersensitivity PRIALT component . Presence contraindication continue IT therapy ( example , infection pump catheter externalization site , uncontrolled bleeding diathesis , spinal canal obstruction impairs cerebrospinal fluid [ CSF ] circulation , patient caregiver inability manage protect IT pump spinal catheter system return clinic follow visit ) . Presence condition ( example , psychosis , severe depression suicidal ideation , homicidality , somatization disorder , active substance abuse , cognitive deficit , dementia serious medical psychiatric condition ) Investigator 's opinion preclude patient 's ability participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Intrathecal</keyword>
</DOC>